Literature DB >> 15679746

Recent life problems and non-fatal overdose among heroin users entering treatment.

Joanne Neale1, Michele Robertson.   

Abstract

AIMS: To investigate the role of recent life problems in non-fatal overdose among heroin users entering various drug treatment settings.
DESIGN: Cross-sectional data from a longitudinal study investigating drug treatment effectiveness.
SETTING: Five prison drug treatment services, three residential rehabilitation units, three residential detoxification units and 21 community drug treatment services located in rural, urban and inner-city areas of Scotland. PARTICIPANTS: Of a total of 793 primary heroin users commencing drug treatment during 2001-02, 337 (42.5%) were prison drug service clients; 91 (11.5%) were residential rehabilitation clients; 97 (12.2%) were residential detoxification clients; and 268 (33.8%) were community drug treatment clients. MEASUREMENTS: Univariate and stepwise multivariate logistic regression analyses examined associations between overdosing in the 90 days prior to treatment entry and basic demographic characteristics, recent drug use and recent life problems.
FINDINGS: Ninety-one study participants (11.5%) reported at least one overdose and 19 (2.4%) reported more than one overdose in the 90 days prior to treatment entry. A chi2 test revealed no significant difference in rates of recent overdosing between the four treatment settings (P = 0.650). Recent drug use and recent life problems-but not demographic characteristics-were associated independently with recent overdosing. However, recent life problems were not associated independently with recent overdosing among clients entering prison, clients entering residential rehabilitation or with multiple recent overdosing.
CONCLUSIONS: Associations between recent life problems and recent overdose were evident, but varied by treatment setting. Treatment providers should identify and address heroin users' life problems as part of a broad strategy of overdose prevention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15679746     DOI: 10.1111/j.1360-0443.2004.00920.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  8 in total

1.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

2.  Factors associated with history of non-fatal overdose among young nonmedical users of prescription drugs.

Authors:  Karol Silva; Sheree M Schrager; Aleksandar Kecojevic; Stephen E Lankenau
Journal:  Drug Alcohol Depend       Date:  2012-09-10       Impact factor: 4.492

3.  Associations among pain, non-medical prescription opioid use, and drug overdose history.

Authors:  Erin E Bonar; Mark A Ilgen; Maureen Walton; Amy S B Bohnert
Journal:  Am J Addict       Date:  2013-06-14

Review 4.  Methadone at tapered doses for the management of opioid withdrawal.

Authors:  Laura Amato; Marina Davoli; Silvia Minozzi; Eliana Ferroni; Robert Ali; Marica Ferri
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

5.  Life events and sexual risk among HIV-negative, heterosexual, methamphetamine users.

Authors:  Shirley J Semple; Steffanie A Strathdee; Jim Zians; Thomas L Patterson
Journal:  J Sex Res       Date:  2010-07

6.  Circumstances of overdose among street-involved, opioid-injecting women: Drug, set, and setting.

Authors:  Janna Ataiants; Alexis M Roth; Silvana Mazzella; Stephen E Lankenau
Journal:  Int J Drug Policy       Date:  2020-02-18

7.  It's time for Canadian community early warning systems for illicit drug overdoses.

Authors:  Sarah J Fielden; David C Marsh
Journal:  Harm Reduct J       Date:  2007-03-28

8.  Contribution of problem drug users' deaths to excess mortality in Scotland: secondary analysis of cohort study.

Authors:  Michael Bloor; Maria Gannon; Gordon Hay; Graham Jackson; Alastair H Leyland; Neil McKeganey
Journal:  BMJ       Date:  2008-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.